UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 386

Sortiert nach

Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT

Leukemia, 2012-06, Vol.26 (6), p.1211-1217

2012

Volltextzugriff (PDF)

Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysis

Journal of internal medicine, 2019-04, Vol.285 (4), p.407-418

2019

Volltextzugriff (PDF)

Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT

Annals of oncology, 2016-06, Vol.27 (6), p.1088-1094

2016

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party

Leukemia, 2016-10, Vol.30 (10), p.2047-2054

2016

Volltextzugriff (PDF)

Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation

Leukemia, 2019-01, Vol.33 (1), p.240-248

2019

Volltextzugriff (PDF)

Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23/MLL rearrangement (MLL-r AML)

Leukemia, 2015-12, Vol.29 (12), p.2375-2381

2015

Volltextzugriff (PDF)

Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with < 10% BM blasts: a report from EBMT

Bone marrow transplantation (Basingstoke), 2013-06, Vol.48 (6), p.761-770

2013

Volltextzugriff (PDF)

Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes

Bone marrow transplantation (Basingstoke), 2017-08, Vol.52 (8), p.1107-1112

2017

Volltextzugriff (PDF)

Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia

Leukemia, 2011-05, Vol.25 (5), p.808-813

2011

Volltextzugriff (PDF)

Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT

Annals of hematology, 2016-12, Vol.95 (12), p.1971-1978

2016

Volltextzugriff (PDF)

EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)

Bone marrow transplantation (Basingstoke), 2019-09, Vol.54 (9), p.1391-1398

2019

Volltextzugriff (PDF)

Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation

Bone marrow transplantation (Basingstoke), 2017-04, Vol.52 (4), p.552-560

2017

Volltextzugriff (PDF)

Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)

Annals of oncology, 2014-05, Vol.25 (5), p.1053-1058

2014

Volltextzugriff (PDF)

Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia

Journal of internal medicine, 2018-04, Vol.283 (4), p.371-379

2018

Volltextzugriff (PDF)

Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation

Bone marrow transplantation (Basingstoke), 2013-11, Vol.48 (11), p.1395-1400

2013

Volltextzugriff (PDF)

More chronic GvHD and non-relapse mortality after peripheral blood stem cell compared with bone marrow in hematopoietic transplantation for paediatric acute lymphoblastic leukemia: a retrospective study on behalf of the EBMT Paediatric Diseases Working Party

Bone marrow transplantation (Basingstoke), 2017-07, Vol.52 (7), p.1071-1073

2017

Volltextzugriff (PDF)

Monosomal karyotype predicts poor survival after allogeneic stem cell transplantation in chromosome 7 abnormal myelodysplastic syndrome and secondary acute myeloid leukemia

Leukemia, 2013-04, Vol.27 (4), p.879-888

2013

Volltextzugriff (PDF)

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

Bone marrow transplantation (Basingstoke), 2017-02, Vol.52 (2), p.209-215

2017

Volltextzugriff (PDF)

Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT

Bone marrow transplantation (Basingstoke), 2015-08, Vol.50 (8), p.1063-1068

2015

Volltextzugriff (PDF)

Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT

Haematologica (Roma), 2016-02, Vol.101 (2), p.248

2016

Volltextzugriff (PDF)

Diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome of the liver: problems of interpretation

Bone marrow transplantation (Basingstoke), 2016-12, Vol.51 (12), p.1633-1635

2016

Volltextzugriff (PDF)

Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party

Bone marrow transplantation (Basingstoke), 2017-11, Vol.52 (11), p.1519-1525

2017

Volltextzugriff (PDF)

What is the outcome in patients with acute leukaemia who survive severe acute graft‐versus‐host disease?

Journal of internal medicine, 2018-02, Vol.283 (2), p.166-177

2018

Volltextzugriff (PDF)

Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT

Bone marrow transplantation (Basingstoke), 2010-03, Vol.45 (3), p.558-564

2010

Volltextzugriff (PDF)

1 – 25 von 386

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(334)
Mit Volltextzugriff
(336)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(218)
Life Sciences & Biomedicine
(187)
Humans
(178)
Adult
(131)
Female
(125)
Biological And Medical Sciences
(121)
Hematology
(119)
Male
(119)
Medical Sciences
(112)
Middle Aged
(110)
Transplantation
(88)
Medicin Och Hälsovetenskap
(81)
Oncology
(79)
Immunology
(78)
Stem Cell Transplantation
(70)
Adolescent
(65)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(59)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(59)
Aged
(58)
Biophysics
(58)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT

Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysis

Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT

Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party

Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation

Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23/MLL rearrangement (MLL-r AML)

Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with < 10% BM blasts: a report from EBMT

Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes

Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia

Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT

EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)

Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation

Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)

Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia

Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation

More chronic GvHD and non-relapse mortality after peripheral blood stem cell compared with bone marrow in hematopoietic transplantation for paediatric acute lymphoblastic leukemia: a retrospective study on behalf of the EBMT Paediatric Diseases Working Party

Monosomal karyotype predicts poor survival after allogeneic stem cell transplantation in chromosome 7 abnormal myelodysplastic syndrome and secondary acute myeloid leukemia

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT

Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT

Diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome of the liver: problems of interpretation

Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party

What is the outcome in patients with acute leukaemia who survive severe acute graft‐versus‐host disease?

Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT

Suchergebnisse filtern